Cardiovascular Medicine


Showing 1-20 of 29 Results

  • Matteo Cartura

    Matteo Cartura

    Postdoctoral Scholar, Cardiovascular Medicine

    BioMatteo Cartura is a postdoctoral researcher in cardiovascular science, focusing on the clinical association between genetic variants identified in GWAS studies and the pathophysiology of atherosclerosis. He obtained his PhD at the Institute for Vascular Signalling, with a research focus on the immunological functions of endothelial cells in atherosclerosis. He holds a Bachelor’s and Master’s degree in Biology and Biotechnology.

  • Joshua Gillard

    Joshua Gillard

    Postdoctoral Scholar, Cardiovascular Medicine

    BioDr. Josh Gillard is a Canadian biomedical data scientist with experience in bioinformatics, machine learning, and immunology. After completing a BSc and a MSc in Experimental Medicine at McGill university, he relocated to the Netherlands for his PhD in bioinformatics at Radboud University in Nijmegen. During his PhD, he gained experience analyzing and interpreting complex immunological data (bulk and single-cell transcriptomics, high-dimensional cytometry, high-throughput proteomics) derived from human observational or intervention studies (vaccination and experimental human infection). This work revealed molecular and cellular correlates of clinically important endpoints such as disease severity, symptom progression, and antibody responses. In 2022, Josh relocated to Stanford to join the Gaudilliere lab to develop and apply multi-omic data integration and machine learning techniques, establishing that early gestational immune dysregulation can predict preterm birth. Since 2024, in the Ashley lab, Josh is developing deep learning models to investigate aberrant splicing in cardiovascular disease.

  • Shreya Gupta

    Shreya Gupta

    Postdoctoral Scholar, Cardiovascular Medicine

    Current Research and Scholarly InterestsI am a biomedical researcher focused on understanding the molecular mechanisms governing vascular smooth muscle cell (SMC) behavior in cardiovascular and metabolic diseases. My work investigates how signaling pathways, including Notch3 and Thrombospondin-1, regulate SMC phenotypic switching, fibrous cap stability, and plaque vulnerability in atherosclerosis, with the goal of identifying novel therapeutic targets to prevent heart attacks and strokes.

  • Edward Guzman

    Edward Guzman

    Postdoctoral Scholar, Cardiovascular Medicine

    BioEdward Guzman is a postdoctoral fellow in cardiovascular medicine at Stanford University. He earned his Ph.D. from Harvard University in collaboration with the Massachusetts Institute of Technology (MIT), focusing on RNA treatments for vascular diseases. His research has advanced the development of novel cardiovascular therapies and deepened our understanding of endothelial cell biology under diseased conditions.

  • Jiaqi Hu

    Jiaqi Hu

    Postdoctoral Scholar, Cardiovascular Medicine

    BioJiaqi Hu is a Postdoctoral Scholar at Stanford University, supervised by Drs. Tim Assimes and Shoa Clarke. She received her PhD in Chronic Disease Epidemiology from the Yale School of Public Health in 2026 and her Bachelor of Arts degree from Peking University in 2021. Her research focuses on identifying genetic variants underlying complex diseases, applying polygenic scores for disease risk prediction and subtype identification, and integrating genetic, environmental, and clinical data to improve individual-level risk stratification.

  • Hirotaka Ieki

    Hirotaka Ieki

    Postdoctoral Scholar, Cardiovascular Medicine

    BioI am an MD, PhD physician-scientist aiming to advance precision medicine for cardiovascular disease through research in genomics and artificial intelligence.

    MD, The University of Tokyo, Tokyo, 2013
    Residency in Internal Medicine, National Center for Global Health and Medicine, Tokyo, 2013-2017
    Residency in Cardiology, Sakakibara Heart Institute, Tokyo, 2015–2017
    PhD, The University of Tokyo, Tokyo, 2021
    Clinical Fellow in Cardiology, The University of Tokyo Hospital, Tokyo, 2021–2022
    Postdoctoral Scholar, Stanford University, 2023–present

    Research interest: Precision medicine in cardiovascular disease. Genomics, Artificial Intelligence

  • Samuel Montalvo

    Samuel Montalvo

    Postdoctoral Scholar, Cardiovascular Medicine

    BioAs a clinical exercise physiologist, sport scientist, and biomechanist, I study the mechanical, physiological, and molecular determinants of human performance and health. I am certified as a Performance and Sport Scientist (CPSS), Strength and Conditioning Specialist with Distinction (CSCS,*D), and Clinical Exercise Physiologist.

    I am a Postdoctoral Scholar in Cardiovascular Medicine at Stanford University and a member of the Stanford Bioinformatics Core and Wu Tsai Human Performance Alliance. My training has been supported by the Wu Tsai Human Performance Alliance Postdoctoral Fellowship, the NIH T32 Research Training in Myocardial Biology at Stanford, and a two-year NIH/NHLBI Loan Repayment Program award in Research in Emerging Areas Critical to Human Health.

    My research integrates clinical exercise physiology, cardiopulmonary exercise testing, biomechanics, and multi-omics to better understand how physical activity influences cardiovascular health, biological adaptation, and athletic performance. Through the NIH-funded Molecular Transducers of Physical Activity Consortium (MoTrPAC), I analyze large clinical, multi-omic, multi-tissue, multimodal, and multi-species datasets to identify mechanisms and biomarkers of exercise response.

    I also collaborate on projects involving sports cardiology and electrocardiography, cardiopulmonary exercise testing, exercise and neuromuscular disease, and athlete performance, including work with Stanford Baseball and external sports-science collaborators.

    I contribute to professional and institutional service as a Senior Editor for the Journal of Strength and Conditioning Research and Financial Officer of the Stanford University Postdoctoral Association (SURPAS).

    Teaching and mentoring are central to my academic work. As a first-generation college graduate and Mexican American with Indigenous heritage, I am committed to creating supportive and inclusive pathways for trainees from underrepresented backgrounds. I serve as a Postdoctoral Mentoring Coach with the Stanford Office of Postdoctoral Affairs and mentor undergraduate, graduate, and medical trainees and residents through several Stanford programs and initiatives, including PRISM and the MAVERICs program within the Stanford Cardiovascular Institute.

    My long-term goal is to lead an independent research program that combines exercise physiology, multi-omics, physical activity, nutrition, cardiovascular science, and sports performance while mentoring the next generation of scientists.

  • Bryan Mosher

    Bryan Mosher

    Clinical Scholar, Medicine - Cardiovascular Medicine
    Postdoctoral Scholar, Cardiovascular Medicine

    BioBryan Mosher, MD, PhD, is a physician-scientist in Adult Congenital Heart Disease at Stanford University. His clinical and research interests focus on understanding the mechanisms that drive cardiovascular dysfunction across the lifespan, with particular emphasis on congenital heart disease, exercise physiology, myocardial remodeling, pulmonary vascular disease, and precision medicine. His research integrates advanced cardiovascular imaging, cardiopulmonary exercise testing, multimodal phenotyping, and emerging single-cell technologies to identify biologically distinct patient phenotypes and develop more individualized approaches to risk stratification and therapy.

    Dr. Mosher completed his pediatric cardiology fellowship at the University of Michigan and advanced fellowship training in Adult Congenital Heart Disease at Stanford. He holds both an MD and PhD, with doctoral training in neuroscience focused on optogenetics and electrophysiology. His long-term goal is to build a translational research program that connects human phenotyping with mechanistic discovery to improve outcomes for patients with congenital and acquired cardiovascular disease.